Cargando…
Infection of non-cancer cells: A barrier or support for oncolytic virotherapy?
Oncolytic viruses are designed to specifically target cancer cells, sparing normal cells. Although numerous studies demonstrate the ability of oncolytic viruses to infect a wide range of non-tumor cells, the significance of this phenomenon for cancer virotherapy is poorly understood. To fill the gap...
Autores principales: | Naumenko, Victor A., Stepanenko, Aleksei A., Lipatova, Anastasiia V., Vishnevskiy, Daniil A., Chekhonin, Vladimir P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898763/ https://www.ncbi.nlm.nih.gov/pubmed/35284629 http://dx.doi.org/10.1016/j.omto.2022.02.004 |
Ejemplares similares
-
In Vivo Tracking for Oncolytic Adenovirus Interactions with Liver Cells
por: Naumenko, Victor A., et al.
Publicado: (2022) -
Recent Advances in Oncolytic Virotherapy and Immunotherapy for Glioblastoma: A Glimmer of Hope in the Search for an Effective Therapy?
por: Stepanenko, Aleksei A., et al.
Publicado: (2018) -
Superior infectivity of the fiber chimeric oncolytic adenoviruses Ad5/35 and Ad5/3 over Ad5-delta-24-RGD in primary glioma cultures
por: Stepanenko, Aleksei A., et al.
Publicado: (2021) -
A new insight into aggregation of oncolytic adenovirus Ad5-delta-24-RGD during CsCl gradient ultracentrifugation
por: Stepanenko, Aleksei A., et al.
Publicado: (2021) -
ONCOLYTIC VIROTHERAPY
por: Russell, Stephen J, et al.
Publicado: (2012)